Sign in
4

Changes in Ownership

INOVIO PHARMACEUTICALS, INC. Filed Acc 0001055726-24-000005

Chief Executive Officer gave up 3,728 shares (to pay taxes)

  • Chief Executive Officer acquired 7,731 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Shea Jacqueline Elizabeth · Chief Executive Officer

Table I: Non-derivative

4 lines
Date Transaction Shares Price Value Owned after D/I
2024-02-26 Exercise or conversion : show line 1 in the form +1,878 18,387 D
2024-02-26 Shares withheld for taxes : show line 2 in the form −872 $8.16 $7,116 17,515 D
2024-02-26 Exercise or conversion : show line 3 in the form +5,853 23,368 D
2024-02-26 Shares withheld for taxes : show line 4 in the form −2,856 $8.16 $23,305 20,512 D

Table II: Derivative

4 lines
Date Transaction Shares Owned after D/I
2024-02-26 Exercise or conversion : show line 5 in the form Restricted Stock Unit −1,878 0 D
2024-02-26 Exercise or conversion : show line 6 in the form Restricted Stock Unit −5,853 5,852 D
2024-02-28 Grant or award : show line 7 in the form Common Stock Option +69,733 69,733 D
2024-02-28 Grant or award : show line 8 in the form Restricted Stock Unit +55,895 55,895 D
Loading xslF345X05/wk-form4_1709158138.xml…